Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GUMM - Eliminate the Common Cold -- Ignore unavailable to you. Want to Upgrade?

To: pz who wrote (1843)	12/7/1999 1:43:00 PM
From: Eric Fader	Read Replies (2) \| Respond to of 5582

Paul - Most normal, rational human beings wouldn't need a dictionary to know that the journal's initial decision to publish GUMM's study was an "acceptance" and a validation of its results and methodology. The "withdrawal," which was plainly stated to have been for extraneous reasons (the excessive publicity, or whatever), clearly was not intended to, and did not, convert the initial "acceptance" of the study into a "rejection." Even someone who doesn't know the difference between "college" and "graduate school" surely knows that, so why don't we simply correct the blatant distortions for the benefit of free-thinking potential investors without arguing with him directly? BTW I picked up a smidgen more GUMM today. Couldn't take advantage of the buying op yesterday but what's a point or so when the upside is 10 or more? -Eric